Multimodal nanoparticle‐containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation

Nhu Truong, Andrea L. Cottingham, Shruti Dharmaraj, Jacob R. Shaw, Jackline Joy Martin Lasola, Christopher C. Goodis, Steven Fletcher and Ryan M. Pearson

Bioengineering & Transla Med, 2024, 9
DOI: 10.1002/btm2.10611

Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance

Hyein Jo, Kyeonghee Shim and Dooil Jeoung

IJMS, 2022, 23, 9592
DOI: 10.3390/ijms23179592

Therapeutic potential of dual HDAC6/SIRT2 inhibition in Alzheimer's disease

Xingyu Wang, Cunjiang Li, Lei Chen, Bin He and Yan Li

European Journal of Medicinal Chemistry, 2025, 294, 117733
DOI: 10.1016/j.ejmech.2025.117733

Augmenting the Anti‐Leukemic Activity of the BCL‐2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL‐2/HDAC1 and Dual BCL‐2/HDAC6 Inhibitors

Alexandria M. Chan, Christian Eberly, Brandon Drennen, Christopher C. Goodis, Zoe Wuyts, Curt I. Civin and Steven Fletcher

Drug Development Research, 2025, 86
DOI: 10.1002/ddr.70084

Histone deacetylase (HDAC) inhibitor specificity determinants are preserved in a class of dual HDAC/non-covalent proteasome inhibitors

Alexandria M. Chan, Ashley Mitchell, Lena Grogan, Paul Shapiro and Steven Fletcher

Bioorganic & Medicinal Chemistry, 2024, 104, 117680
DOI: 10.1016/j.bmc.2024.117680

β-Carboline tethered cinnamoyl 2-aminobenzamides as class I selective HDAC inhibitors: Design, synthesis, biological activities and modelling studies

Hari Krishna Namballa, Pratibha Anchi, Kesari Lakshmi Manasa, Jay Prakash Soni, Chandraiah Godugu, Nagula Shankaraiah and Ahmed Kamal

Bioorganic Chemistry, 2021, 117, 105461
DOI: 10.1016/j.bioorg.2021.105461

Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge

Nhu Truong, Christopher C. Goodis, Andrea L. Cottingham, Jacob R. Shaw, Steven Fletcher and Ryan M. Pearson

ACS Pharmacol. Transl. Sci., 2022, 5, 1128
DOI: 10.1021/acsptsci.2c00119

Recent progress in synthetic strategies to develop potent, HDAC8-selective, small-molecule inhibitors

Brandon D. Lowe and Steven Fletcher

Bioorganic & Medicinal Chemistry Letters, 2025, 128, 130312
DOI: 10.1016/j.bmcl.2025.130312

A Review on the Anticancer Activity of Carbazole-based Tricyclic Compounds

Hua Zhang, Wen Zhang, Mengyu Zhu and Annoor Awadasseid

CMC, 2024, 31, 4826
DOI: 10.2174/0929867331666230825104254